* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Name
Gene expression programming wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Point mutation wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Microevolution wikipedia , lookup
Epigenetics of diabetes Type 2 wikipedia , lookup
Epigenetics in stem-cell differentiation wikipedia , lookup
Designer baby wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Gene expression profiling wikipedia , lookup
Genome (book) wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Cancer epigenetics wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Mir-92 microRNA precursor family wikipedia , lookup
Secreted frizzled-related protein 1 wikipedia , lookup
Name Prof. Yi-Ching Wang (王憶卿 特聘教授) Affiliations Institute of Basic Medical Sciences & Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.(成大基礎醫學所&藥理所) TEL:06-2353535 ext.5502 E-mail: [email protected] Biography Dr. Yi-Ching Wang studies the molecular mechanisms involved in lung tumorigenesis. Dr. Wang investigates the etiological association of alterations in tumor suppressor genes and oncogenes with lung tumorigenesis. The alteration analyses include the following aspects: gene mutation and polymorphism, gene loss, hypermethylation of promoter, chromatin structure alteration of gene locus, mRNA alteration, and protein expression alteration. More recently, Dr. Wang has continued to do research on cancer genomics and epigenomics such as genome-wide search of loss of heterozygosity, and genome-scanning approaches of DNA methylation and chromatin alteration profiles for identification of new genes critical to lung tumorigenesis. Several potential anti-cancer drugs also are developing in her laboratory. Dr. Wang has published more than 80 SCI papers on lung cancer including prestigious journals such as J Clin Oncol, J Clin Invest, Cancer Res, and Nat Commun. Dr. Wang is one of the recipients of the Excellent Research Award of Taiwan Ministry of Science and Technology. Abstract (1) The role of small GTPase Rab37 in regulation of exocytosis and cell motility (2) Rab small GTPases are master regulators of membrane trafficking and guide vesicle targeting. Recent publications show that Rab-controlled trafficking pathways are altered during tumorigenesis. However, whether any of the Rabs plays a metastasis suppressor role is least explored. Here, we address the metastasis suppressive function of human Rab37 (hRAB37) using secretomics, cell, animal, and clinical analyses. We show that tissue inhibitor of metalloproteinase 1 (TIMP1), a secreted glycoprotein that inhibits extracellular matrix turnover, is a novel cargo of hRAB37. hRAB37 regulates the exocytosis of TIMP1 in a nucleotide-dependent manner to inactivate matrix metalloproteinase 9 (MMP9) migration axis in vitro and in vivo. Dysfunction of hRAB37 or TIMP1 abrogates metastasis suppression. Lung cancer patients with metastasis and poor survival show low hRAB37 protein expression coinciding with low TIMP1 in tumors. Our findings identify hRAB37 as a novel metastasis suppressor Rab that functions through the TIMP1-MMP9 pathway and has significant prognostic power. Additionally, the effectors in Rab37-mediated exocytosis and their role in cancer cell motility control will be discussed in my speech.